UnknownPhase 4

Balanced Propofol Sedation Versus Propofol Alone Sedation in Therapeutic Endoscopic Retrograde Cholangiopancreatography (ERCP)

204 participantsStarted 2011-04

Plain-language summary

Based on previous results, the investigators considered that sedation quality, complications, and procedure outcomes may not be different, however, propofol alone titration may have a fast recovery time than BPS and cost-effectiveness than balanced propofol sedation (BPS). In present study, the investigators therefore evaluate the time and sedation quality of patient recovery, cost-effectiveness, complication, and procedure outcomes between propofol alone and BPS in therapeutic endoscopic retrograde cholangiopancreatography (ERCP).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * candidates for therapeutic ERCP Exclusion Criteria: * patient age \< 18 years * pregnant women * inability to provide informed consent * patients with total gastrectomy * American Society of Anesthesiologist (ASA) Class V patients * patients with known respiratory disease, patients with neurologic impairment * patients with known allergy to the drugs used, history of complications with previous sedation

What they're measuring

Recovery time and cost-effectiveness

Timeframe: SIX MONTH

Trial details

NCT IDNCT01321047

SponsorSoon Chun Hyang University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-09

View on ClinicalTrials.gov More Conscious Sedation Failure During Procedure trials